Treatment and endpoints. – AIEOP-BFM ALL – AIEOP-BFM ALL • Perspectives. ALL, acute lymphoblastic leukemia; MRD, minimal residual disease. Principal investigator of clinical trial. Pr Martin SCHRAPPE; Klinik für Kinder- und Jugendmedizin I; Universitätsklinikum Schleswig-Holstein – Campus Kiel. Blood ; doi: .. Accordingly, in the AIEOP-BFM ALL study, these 2 groups of patients.
|Published (Last):||11 July 2008|
|PDF File Size:||4.23 Mb|
|ePub File Size:||11.77 Mb|
|Price:||Free* [*Free Regsitration Required]|
Cancer AND drug name. Pneumonia AND sponsor name.
AIEOP-BFM ALL 2009
How to search [pdf]. For these items you should use aieop-bbfm filters and not add them to your search terms in the text field. Trials with results Trials without results Clear advanced search filters.
Download Options Subscribe to this Search.
Displaying page 1 of 1. International collaborative treatment protocol for children and adolescents aieopp-bfm acute lymphoblastic leukemia Medical condition: Children, Adolescents, Under 18 Gender: Male, Female Trial protocol: No results available EudraCT Number: Anna Kinderkrebsforschung Full Title: This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Clinical Trials Register
Date study was submitted in EudraCT. Query did sieop-bfm match any studies. EU Clinical Trials Register. Both Female Only Male Only. IMP with orphan designation in the indication. Trials with results Trials without results.
Clear advanced search filters. Information not available in EudraCT.
International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia. Infants and toddlers, Children, Adolescents, Under 18, Adults. Trials shown on current page Selected Trials only. Summary Details Full Trial Details.